focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEngage Xr Regulatory News (EXR)

Share Price Information for Engage Xr (EXR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.85
Bid: 1.80
Ask: 1.90
Change: 0.00 (0.00%)
Spread: 0.10 (5.556%)
Open: 1.85
High: 1.85
Low: 1.85
Prev. Close: 1.85
EXR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EPT Disclosure

1 May 2008 11:27

UBS AG (EPT)01 May 2008 FORM 38.5(b) DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITHOUT RECOGNISED INTERMEDIARY STATUS, OR WITH RI STATUS BUT NOT DEALING IN A CLIENT-SERVING CAPACITY (Rule 38.5(b) of the Takeover Code) 1. KEY INFORMATION Name of exempt principal trader UBS AG London BranchCompany dealt in Expro International Group PlcClass of relevant security to which the 10p Ordinarydealings being disclosed relate (Note 1)Date of dealing 30 APRIL 2008 2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE (a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 2) Long Short Number (%) Number (%)(1) Relevant securities 543,600 0.49% 205 0.00%(2) Derivatives (other thanoptions)(3) Options and agreements topurchase/sellTotal 543,600 0.49% 205 0.00% (b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 2) Class of relevant security: Long Short Number (%) Number (%)(1) Relevant securities(2) Derivatives (other thanoptions)(3) Options and agreements topurchase/sellTotal (c) Rights to subscribe (Note 2)Class of relevant security: Details 3. DEALINGS (Note 3) (a) Purchases and sales Purchase/sale Number of securities Price per unit (Note 4) SALE 4966 1510 pence SALE 3970 1510 SALE 996 1510 PURCHASE 21 1510 PURCHASE 50 1511 PURCHASE 50 1511 PURCHASE 74 1511 PURCHASE 293 1511 PURCHASE 373 1511 PURCHASE 505 1511 PURCHASE 531 1511 PURCHASE 560 1511 PURCHASE 755 1511 PURCHASE 1100 1511 PURCHASE 2400 1511 PURCHASE 3900 1512 PURCHASE 51 1513 PURCHASE 60 1513 PURCHASE 79 1513 PURCHASE 195 1513 PURCHASE 500 1513 PURCHASE 600 1513 PURCHASE 1104 1513 PURCHASE 296 1514 PURCHASE 554 1514 SALE 3364 1515 SALE 1483 1515 SALE 894 1515 SALE 875 1515 SALE 278 1515 SALE 122 1515 SALE 111 1515 PURCHASE 21 1516 PURCHASE 4947 1516 SALE 850 1517 SALE 277 1517 SALE 200 1517 SALE 134 1517 SALE 129 1517 SALE 98 1517 SALE 9 1517 SALE 3 1517 PURCHASE 21 1517 SALE 1150 1518 SALE 589 1518 SALE 200 1518 SALE 93 1518 SALE 50 1518 PURCHASE 17 1518 PURCHASE 885 1518 PURCHASE 1150 1518 SALE 1352 1519 SALE 777 1519 SALE 440 1519 SALE 358 1519 SALE 330 1519 SALE 300 1519 SALE 266 1519 SALE 266 1519 SALE 252 1519 SALE 251 1519 SALE 163 1519 SALE 115 1519 SALE 114 1519 SALE 98 1519 SALE 71 1519 SALE 70 1519 SALE 50 1519 SALE 39 1519 SALE 27 1519 SALE 24 1519 PURCHASE 2 1519 PURCHASE 18 1519 PURCHASE 4934 1520 TOTAL PURCHASES 26,046 TOTAL SALES 26,204 (b) Derivatives transactions (other than options)Product name, e.g Long/short (Note 5) Number of securities Price per unitCFD (Note 6) (Note 4) (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying Product Writing, Number of Exercise Type, e.g. Expiry Optionname,e.g. selling, securities price American, date money paid/call purchasing, to which the European received peroption varying etc option etc. unit (Note relates 4) (Note 6) (ii) Exercising Product name, e.g. call Number of securities Exercise price per unitoption (Note 4) (d) Other dealings (including new securities) (Note 3) Nature of transaction Details Price per unit (if applicable)(Note 7) 4. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the persondisclosing and any other person relating to the voting rights of any relevantsecurities under any option referred to on this form or relating to the votingrights or future acquisition or disposal of any relevant securities to which anyderivative referred to on this form is referenced. If none, this should bestated. .............................................................................. .............................................................................. Is a Supplemental Form 38.5(b) attached? (Note 8) NO Date of disclosure 1 MAY 2008Contact name LOUISE ROBINSONTelephone number 020 7567 8762Name of offeree/offeror with which connected Halliburton CompanyNature of connection (Note 9) CONNECTED ADVISER Notes The Notes on Form 38.5(b) can be viewed on the Takeover Panel's website atwww.thetakeoverpanel.org.uk This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
23rd Apr 202412:53 pmRNSDirector/PDMR Shareholding
15th Apr 20247:00 amRNSFinal Results
28th Mar 20247:00 amRNSNotice of Results & Investor Presentation
13th Mar 20247:00 amRNSLaunch of School of AI
26th Feb 20247:00 amRNSTrading Update
23rd Feb 20247:00 amRNSHolding(s) in Company
20th Feb 20247:00 amRNSMajor Contract Wins
19th Dec 20237:00 amRNSTrading Update
8th Dec 20237:00 amRNSBoard Change
11th Sep 20237:00 amRNSInterim Results
31st Aug 20237:00 amRNSNotice of Investor Presentation
3rd Aug 20237:00 amRNSGrant of Options
1st Aug 20237:00 amRNSPre-Close Trading Update and Notice of Results
29th Jun 20232:23 pmRNSResult of AGM
7th Jun 20237:00 amRNSNotice of AGM
1st Jun 20237:00 amRNSLaunch of Lenovo’s new VR headset
23rd May 20237:00 amRNSFinal Results
12th May 20237:00 amRNSInvestor Presentation
27th Apr 20237:00 amRNSTrading Update & Notice of Results
31st Mar 20237:00 amRNSFatboy Slim concert takes place in ENGAGE Link
21st Mar 20237:00 amRNSCancellation of Admission to Euronext Growth
17th Mar 20237:00 amRNSFatboy Slim set to perform in ENGAGE
8th Mar 20231:05 pmRNSTR-1: Notification of major holdings
7th Mar 20235:30 pmRNSTR-1: Notification of major holdings
7th Mar 20232:19 pmRNSTR-1: Notification of major holdings
6th Mar 20234:50 pmRNSTR-1: Notification of major holdings
3rd Mar 202312:00 pmRNSResult of EGM
27th Feb 20233:45 pmRNSSigning of Subscription Agreement and TVR
7th Feb 202311:45 amRNSPosting of Circular
6th Feb 202312:00 pmRNS£8.8 million Placing
6th Feb 20237:00 amRNSProposed Placing of New Ordinary Shares
31st Jan 202311:05 amRNSSecond Price Monitoring Extn
31st Jan 202311:00 amRNSPrice Monitoring Extension
23rd Jan 20237:00 amRNSENGAGE showcases first AI-powered virtual employee
18th Jan 20237:00 amRNSFY2022 Trading Update and Notice of Results
12th Dec 20222:05 pmRNSSecond Price Monitoring Extn
12th Dec 20222:00 pmRNSPrice Monitoring Extension
12th Dec 202211:05 amRNSSecond Price Monitoring Extn
12th Dec 202211:00 amRNSPrice Monitoring Extension
12th Dec 20227:00 amRNSTrading Update
21st Nov 20227:00 amRNSCommercial reseller agreement signed with Lenovo
7th Nov 20227:00 amRNSLaunch of ENGAGE Link & Investor Presentation
28th Sep 202211:00 amRNSENGAGE XR to collaborate with Lenovo
21st Sep 20222:09 pmRNSHolding(s) in Company
13th Sep 20227:00 amRNSInterim Results
16th Aug 20227:00 amRNSInvestor Presentation
2nd Aug 20227:00 amRNSPre-Close Trading Update and Notice of Results
18th Jul 202211:00 amRNSDirectors’ Disclosure
23rd Jun 20227:00 amRNSENGAGE & METAVERSE UPDATE
16th Jun 202211:58 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.